CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.200
-0.010 (-0.24%)
Mar 17, 2025, 1:17 PM EDT - Market open
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 4.67, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 11.19% from the current stock price of 4.20.
Analyst Consensus: Hold
* Price targets were last updated on Jan 30, 2025.
Analyst Ratings
The average analyst rating for CARGO Therapeutics stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 0 | 0 | 0 |
| Buy | 3 | 4 | 4 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $32 → $7 | Strong Buy → Hold | Downgrades | $32 → $7 | +66.67% | Jan 30, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $34 → $4 | Buy → Hold | Downgrades | $34 → $4 | -4.76% | Jan 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Jan 30, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.20M
EPS This Year
-2.43
from -3.72
EPS Next Year
-2.37
from -2.43
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 31.5M | 323.0M | ||
| Avg | n/a | 7.2M | 158.6M | ||
| Low | n/a | n/a | 33,320 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 4,383.3% | ||
| Avg | - | - | 2,102.1% | ||
| Low | - | - | -99.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.31 | -1.06 | -0.80 | ||
| Avg | -2.43 | -2.37 | -2.14 | ||
| Low | -4.31 | -4.70 | -4.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.